{"schema_version":"secwatch.filing_event.v1","accession":"0001558370-25-001095","form_type":"8-K","ticker":"TCMD","cik":"0001027838","company_name":"TACTILE SYSTEMS TECHNOLOGY INC","filed_at":"2025-02-18T23:59:59+00:00","discovered_at":"2026-05-14T18:03:02.737545+00:00","generated_at":"2026-05-26T13:13:04.692567+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Tactile Medical Q4 rev $85.6M (+10%), net income $9.7M; guides FY25 rev $316-322M","bullets":["Q4 total revenue $85.6M (+10% YoY); gross margin 75.2% vs 72.1% YoY.","Q4 net income $9.7M ($0.40 diluted EPS) vs $8.2M ($0.35) YoY.","FY2024 revenue $293.0M (+7%); net income $17.0M vs $28.5M in 2023.","Cash $94.4M at year-end, up from $61.0M; $26.5M remaining share repurchase authorization.","FY2025 revenue guidance $316-322M (8-10% growth); adjusted EBITDA $35-37M vs $37.1M in 2024."],"urls":{"canonical":"https://secwatch.observer/filing/0001558370-25-001095","json":"https://secwatch.observer/filing/0001558370-25-001095.json","markdown":"https://secwatch.observer/filing/0001558370-25-001095.md","text":"https://secwatch.observer/filing/0001558370-25-001095.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1027838/000155837025001095/0001558370-25-001095-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1027838/000155837025001095/tcmd-20250218x8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-26T13:13:04.692567+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}